• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characterization of Gp41 polymorphisms in the fusion peptide domain and T-20 (Enfuvirtide) resistance-associated regions in Korean HIV-1 isolates.韩国HIV-1分离株中融合肽结构域及T-20(恩夫韦肽)耐药相关区域的Gp41多态性特征分析
J Korean Med Sci. 2014 Mar;29(3):456-9. doi: 10.3346/jkms.2014.29.3.456. Epub 2014 Feb 27.
2
Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naïve Korean patients.来自未接受过恩夫韦肽治疗的韩国患者的HIV-1分离株中HIV-1 gp41天然多态性的功能特征
Arch Virol. 2016 Jun;161(6):1547-57. doi: 10.1007/s00705-016-2807-x. Epub 2016 Mar 21.
3
Genetic analysis and natural polymorphisms in HIV-1 gp41 isolates from Maputo City, Mozambique.来自莫桑比克马普托市的HIV-1 gp41分离株的基因分析及自然多态性
AIDS Res Hum Retroviruses. 2014 Jun;30(6):603-9. doi: 10.1089/aid.2013.0244. Epub 2013 Dec 21.
4
Genotypic analysis of the gp41 HR1 region from HIV-1 isolates from enfuvirtide-treated and untreated patients.对恩夫韦肽治疗和未治疗的 HIV-1 分离株中 gp41 HR1 区的基因分析。
J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 3:S197-201. doi: 10.1097/QAI.0b013e31821e9d29.
5
Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors.在美国,在HIV进入抑制剂可用之前就已感染HIV的男性中,对1型HIV gp41和恩夫韦肽敏感性的分析。
AIDS Res Hum Retroviruses. 2009 Jul;25(7):701-5. doi: 10.1089/aid.2009.0014.
6
Natural resistance-associated mutations to Enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients.初治患者中针对恩夫韦肽(T20)的天然耐药相关突变以及不同HIV-1基因亚型gp41区域的多态性
J Clin Virol. 2005 Mar;32(3):248-53. doi: 10.1016/j.jcv.2004.11.009.
7
Short communication: high polymorphism rates in the HR1 and HR2 gp41 and presence of primary resistance-related mutations in HIV type 1 circulating in Brazil: possible impact on enfuvirtide efficacy.简短通讯:巴西流行的1型人类免疫缺陷病毒(HIV-1)中gp41的HR1和HR2区域多态性率高以及存在与原发性耐药相关的突变:对恩夫韦肽疗效的可能影响
AIDS Res Hum Retroviruses. 2010 Mar;26(3):307-11. doi: 10.1089/aid.2008.0297.
8
The HR2 polymorphism N140I in the HIV-1 gp41 combined with the HR1 V38A mutation is associated with a less cytopathic phenotype.HIV-1 gp41 中的 HR2 多态性 N140I 与 HR1 V38A 突变相结合与细胞病变表型减少相关。
Retrovirology. 2012 Feb 14;9:15. doi: 10.1186/1742-4690-9-15.
9
Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro.在恩夫韦肽治疗期间选择的1型人类免疫缺陷病毒gp41氨基酸取代对恩夫韦肽体外gp41结合及抗病毒效力的影响
J Virol. 2005 Oct;79(19):12447-54. doi: 10.1128/JVI.79.19.12447-12454.2005.
10
[Analysis of the polymorphism of the genome region of HIV-1 encoding the fusion protein].[人类免疫缺陷病毒1型融合蛋白编码基因组区域的多态性分析]
Vopr Virusol. 2012 Jul-Aug;57(4):9-13.

本文引用的文献

1
Update of the drug resistance mutations in HIV-1: March 2013.2013年3月HIV-1耐药性突变的更新情况
Top Antivir Med. 2013 Feb-Mar;21(1):6-14.
2
Mechanism of resistance to S138A substituted enfuvirtide and its application to peptide design.S138A 取代恩夫韦肽的耐药机制及其在肽设计中的应用。
Int J Biochem Cell Biol. 2013 Apr;45(4):908-15. doi: 10.1016/j.biocel.2013.01.015. Epub 2013 Jan 26.
3
Ten-year trends in HIV prevalence among visitors to public health centers under the National HIV Surveillance System in Korea, 2000 to 2009.2000 年至 2009 年期间,韩国国家艾滋病监测系统中公共卫生中心就诊者中 HIV 流行率的 10 年趋势。
BMC Public Health. 2012 Sep 28;12:831. doi: 10.1186/1471-2458-12-831.
4
Estimating the origin and evolution characteristics for Korean HIV type 1 subtype B using Bayesian phylogenetic analysis.利用贝叶斯系统发育分析估计韩国1型艾滋病病毒B亚型的起源和进化特征。
AIDS Res Hum Retroviruses. 2012 Aug;28(8):880-4. doi: 10.1089/AID.2011.0267. Epub 2012 Mar 8.
5
Genotypic analysis of the gp41 HR1 region from HIV-1 isolates from enfuvirtide-treated and untreated patients.对恩夫韦肽治疗和未治疗的 HIV-1 分离株中 gp41 HR1 区的基因分析。
J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 3:S197-201. doi: 10.1097/QAI.0b013e31821e9d29.
6
Genetic variation of the HIV-1 integrase region in newly diagnosed anti-retroviral drug-naïve patients with HIV/AIDS in Korea.韩国新诊断为 HIV/AIDS 的抗逆转录病毒药物初治患者中 HIV-1 整合酶区的遗传变异。
Clin Microbiol Infect. 2011 Aug;17(8):1155-9. doi: 10.1111/j.1469-0691.2010.03392.x. Epub 2010 Dec 3.
7
Short communication: high polymorphism rates in the HR1 and HR2 gp41 and presence of primary resistance-related mutations in HIV type 1 circulating in Brazil: possible impact on enfuvirtide efficacy.简短通讯:巴西流行的1型人类免疫缺陷病毒(HIV-1)中gp41的HR1和HR2区域多态性率高以及存在与原发性耐药相关的突变:对恩夫韦肽疗效的可能影响
AIDS Res Hum Retroviruses. 2010 Mar;26(3):307-11. doi: 10.1089/aid.2008.0297.
8
Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors.在美国,在HIV进入抑制剂可用之前就已感染HIV的男性中,对1型HIV gp41和恩夫韦肽敏感性的分析。
AIDS Res Hum Retroviruses. 2009 Jul;25(7):701-5. doi: 10.1089/aid.2009.0014.
9
Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapy.
Virus Genes. 2007 Oct;35(2):167-74. doi: 10.1007/s11262-007-0098-8. Epub 2007 Apr 18.
10
Update of the drug resistance mutations in HIV-1: Fall 2006.2006年秋季HIV-1耐药性突变更新
Top HIV Med. 2006 Aug-Sep;14(3):125-30.

韩国HIV-1分离株中融合肽结构域及T-20(恩夫韦肽)耐药相关区域的Gp41多态性特征分析

Characterization of Gp41 polymorphisms in the fusion peptide domain and T-20 (Enfuvirtide) resistance-associated regions in Korean HIV-1 isolates.

作者信息

Jang Dai-Ho, Yoon Cheol-Hee, Choi Byeong-Sun, Chung Yoon-Seok, Kim Hye-Young, Chi Sung-Gil, Kim Sung Soon

机构信息

Division of AIDS, Korea National Institute of Health, Cheongwon, Korea. ; School of Life Sciences and Biotechnology, Korea University, Seoul, Korea.

Division of AIDS, Korea National Institute of Health, Cheongwon, Korea.

出版信息

J Korean Med Sci. 2014 Mar;29(3):456-9. doi: 10.3346/jkms.2014.29.3.456. Epub 2014 Feb 27.

DOI:10.3346/jkms.2014.29.3.456
PMID:24616600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3945146/
Abstract

HIV-1 gp41 is an envelope protein that plays an essential role in virus entry. The mutation of gp41 affects HIV-1 entry and susceptibility to the fusion inhibitor T-20. Therefore, we analyzed the natural polymorphism of gp41 of 163 HIV-1 isolates from T-20-naïve Koreans infected with HIV-1. This study of gp41 polymorphisms showed that insertions in the fourth threonine (74.8%) and L7M substitutions (85.3%) were more frequent in the fusion peptide motif in Korean HIV-1 isolates compared with those from other countries. Minor T-20 resistance mutations such as L45M (1.2%), N126K (1.2%), and E137K (6.7%) were detected, but the critical T-20 resistance mutations were not detected in the gp41 HR1 and HR2 regions. In addition, the N42S mutation (12.9%) associated with T-20 hypersusceptibility was detected at a high frequency. These results may serve as useful data for studies considering T-20 for use in the development of a more effective anti-retroviral treatment in Korea.

摘要

HIV-1 gp41是一种包膜蛋白,在病毒进入过程中起关键作用。gp41的突变会影响HIV-1的进入以及对融合抑制剂T-20的敏感性。因此,我们分析了163例未接受过T-20治疗的韩国HIV-1感染者的HIV-1分离株中gp41的自然多态性。这项关于gp41多态性的研究表明,与其他国家的HIV-1分离株相比,韩国HIV-1分离株融合肽基序中第四个苏氨酸插入(74.8%)和L7M替换(85.3%)更为常见。检测到了一些轻微的T-20耐药突变,如L45M(1.2%)、N126K(1.2%)和E137K(6.7%),但在gp41 HR1和HR2区域未检测到关键的T-20耐药突变。此外,还高频检测到了与T-20超敏感性相关的N42S突变(12.9%)。这些结果可为韩国考虑使用T-20开发更有效的抗逆转录病毒治疗的研究提供有用数据。